Clinical Trials Logo
  1. Home
  2. Heart Failure, Congestive
  3. NCT00156234
  4. Details
NCT00156234 Clinical Trial

Skeletal Muscle Dysfunction in Heart Failure

Heart Failure, Congestive Clinical Trial

Official title:
Training and Congestive Heart Failure

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT00156234
Other study ID # TRUST-001
Secondary ID Helse ØstHelse o
Status Recruiting
Phase N/A
First received September 8, 2005
Last updated September 8, 2005
Start date March 2005

Study information
Verified date September 2005
Source Ullevaal University Hospital
Contact n/a
Is FDA regulated No
Health authority Norway:National Committee for Medical and Health Research Ethics
Study type Interventional

Clinical Trial Summary

Patients suffering from congestive heart failure report reduced exercise capacity. This skeletal muscle dysfunction is also detectable when using small muscle groups which should not put any demand on the heart.

We hypothesize that congestive heart failure has systemic effects that causes the skeletal muscle dysfunction.

Recruitment information / eligibility
Status Recruiting
Enrollment 45
Est. completion date
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 40 Years to 78 Years
Eligibility Inclusion Criteria:

- Coronary Heart Failure

- Ejection fraction <35%

- NYHA 2-3

- Spirometry FEV1 > 80%

Exclusion Criteria:

- Cardiomyopathy

- Transplantation candidate

- Active malignancy

- Restraining skeletal-muscular disease

- Claudication in legs

- Hospitalized last 30 days due to acute ischemic episode

- Intravenous inotrope or vasodilatating drugs last 14 days prior to inclusion

- AMI last 8 weeks prior to inclusion

- Organized training last 4 months

- Smoking on daily basis last 4 months

- Creatinin < 150microliters/liter

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Educational/Counseling/Training

Related Conditions & MeSH terms

Intervention

Behavioral:
• One-knee extension ergometer

Locations
Country Name City State
Norway Institute for Experimental Medical Research Oslo
Norway Norwegian School of Sport Sciences Oslo

Sponsors (5)
Lead Sponsor Collaborator
Ullevaal University Hospital Norwegian Health Association, Norwegian School of Sport Sciences, The Research Council of Norway, University of Oslo

Country where clinical trial is conducted

Norway, 

See also
  Status Clinical Trial Phase
Completed NCT01357850 - A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure Phase 2
Recruiting NCT00532688 - N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure Phase 2/Phase 3
Completed NCT00531661 - CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients N/A
Terminated NCT00383630 - Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure Phase 2
Completed NCT00159614 - Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment Phase 2
Completed NCT00149435 - Cardiovascular Health Study (CHS) Events Follow-up Study
Terminated NCT00125437 - Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy N/A
Completed NCT00241761 - Epidemiology of Depression and Heart Failure in Aging N/A
Terminated NCT00357591 - Randomized Trial for Patients With Chronic Heart Failure With Acute Decompensation N/A
Completed NCT00094263 - Long-Term Predictors of Morbidity in Older Age N/A
Completed NCT00202579 - Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure Phase 2
Completed NCT00048425 - Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure. Phase 3
Completed NCT00530426 - Heart Failure Registry Phase 4
Completed NCT00023556 - Genetic Architecture of Heart Disease in Rural Brazil N/A
Terminated NCT00190359 - Growth Hormone and Heart Failure N/A
Completed NCT00004562 - Occluded Artery Trial (OAT) Phase 3
Completed NCT00005265 - Natural History of Coronary Heart Disease N/A
Completed NCT02772068 - Hemodynamic Response to Exercise in HFpEF Patients After Upregulation of SERCA2a Early Phase 1
Completed NCT02925546 - A Phase I Study to Assess the Pharmacokinetics of GSK2798745 Tablets Phase 1
Completed NCT01074307 - A Prospective, Open-labeled, Multi-centric Trial in Subjects With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in Korea Phase 4